The U.S. Food and Drug Administration (FDA) has approved the Medtronic Arctic Front® Cardiac CryoAblation Catheter system for the treatment of paroxysmal atrial fibrillation. This is the first cryo (freezing) catheter ablation system to receive approval in the US. Approval was based on the results of the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial that reported higher success at one year than medications along with reduced AF symptoms and improved quality of life.
To learn more, see the story below, and then please come back here to post your thoughts and comments below.
Cryo Catheter Ablation System Approved for Treatment of Paroxysmal Atrial Fibrillation in the U.S.